Thomas P. Beyer

1.6k total citations
22 papers, 1.2k citations indexed

About

Thomas P. Beyer is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Thomas P. Beyer has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 13 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Thomas P. Beyer's work include Cholesterol and Lipid Metabolism (12 papers), Drug Transport and Resistance Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Thomas P. Beyer is often cited by papers focused on Cholesterol and Lipid Metabolism (12 papers), Drug Transport and Resistance Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Thomas P. Beyer collaborates with scholars based in United States, China and Denmark. Thomas P. Beyer's co-authors include Youyan Zhang, Robert J. Schmidt, Patrick I. Eacho, Guoqing Cao, Xian‐Cheng Jiang, Guoqing Cao, William R. Bensch, Robert J. Konrad, Liang Yu and Yuewei Qian and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Thomas P. Beyer

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas P. Beyer United States	16	772	518	239	207	169	22	1.2k
Dayami Lopez United States	23	707 0.9×	689 1.3×	159 0.7×	368 1.8×	249 1.5×	51	1.5k
William R. Bensch United States	16	580 0.8×	638 1.2×	298 1.2×	347 1.7×	182 1.1×	18	1.6k
Bo Angelin Sweden	11	630 0.8×	398 0.8×	228 1.0×	434 2.1×	223 1.3×	17	1.4k
Eric J. Niesor Switzerland	24	905 1.2×	683 1.3×	391 1.6×	546 2.6×	361 2.1×	67	1.8k
George W. Melchior United States	18	783 1.0×	497 1.0×	183 0.8×	449 2.2×	233 1.4×	38	1.3k
Dilip D. Patel United Kingdom	15	502 0.7×	537 1.0×	143 0.6×	156 0.8×	194 1.1×	23	1.0k
Korekiyo Wakitani Japan	17	458 0.6×	331 0.6×	86 0.4×	339 1.6×	161 1.0×	31	1.1k
Gemma Llaverı́as Spain	21	518 0.7×	591 1.1×	197 0.8×	95 0.5×	431 2.6×	29	1.2k
Eric T. Alexander United States	18	692 0.9×	626 1.2×	178 0.7×	443 2.1×	240 1.4×	27	1.4k
Christine K. Castle United States	16	482 0.6×	375 0.7×	98 0.4×	311 1.5×	145 0.9×	24	899

Countries citing papers authored by Thomas P. Beyer

Since Specialization

Citations

This map shows the geographic impact of Thomas P. Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Beyer more than expected).

Fields of papers citing papers by Thomas P. Beyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Beyer. The network helps show where Thomas P. Beyer may publish in the future.

Co-authorship network of co-authors of Thomas P. Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Beyer. A scholar is included among the top collaborators of Thomas P. Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Beyer. Thomas P. Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaudet, Daniel, Malgorzata D. Gonciarz, Xi Shen, et al.. (2025). Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial. Nature Medicine. 31(8). 2632–2639. 6 indexed citations

Balasubramaniam, Deepa, Oliver C. Schroeder, Jonathan R. Fitchett, et al.. (2022). An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. Journal of Lipid Research. 63(5). 100198–100198. 32 indexed citations

Eacho, Patrick I., Krista Schroeder, Thomas P. Beyer, et al.. (2015). NOVEL MECHANISM FOR THE SUSTAINED DURABILITY OF PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 MONOCLONAL ANTIBODY LY3015014. Journal of the American College of Cardiology. 65(10). A1577–A1577. 3 indexed citations

Schroeder, Krista, Thomas P. Beyer, Ryan J. Hansen, et al.. (2015). Proteolytic cleavage of antigen extends the durability of an anti-PCSK9 monoclonal antibody. Journal of Lipid Research. 56(11). 2124–2132. 22 indexed citations

Beyer, Thomas P., Patrick I. Eacho, Krista Schroeder, et al.. (2015). Abstract 538: A PCSK9 Antibody that Blocks Binding to LDLR while Allowing Normal PCSK9 Inactivation by Furin is Afforded a Reduced Clearance Rate and a Longer Duration of Effect in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 35(suppl_1). 2 indexed citations

Escribano, Ana, Sandra L. Cockerham, Thomas P. Beyer, et al.. (2012). Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(11). 3671–3675. 9 indexed citations

Escribano, Ana, Saravanan Parthasarathy, Xiaodong Wang, et al.. (2012). Design, synthesis and structure–activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(9). 3056–3062. 25 indexed citations

Cao, Guoqing, Thomas P. Beyer, Youyan Zhang, et al.. (2011). Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure. Journal of Lipid Research. 52(12). 2169–2176. 93 indexed citations

Schmidt, Robert J., Thomas P. Beyer, William R. Bensch, et al.. (2008). Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo. Biochemical and Biophysical Research Communications. 370(4). 634–640. 85 indexed citations

10.

Qian, Yuewei, Robert J. Schmidt, Youyan Zhang, et al.. (2007). Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis. Journal of Lipid Research. 48(7). 1488–1498. 194 indexed citations

11.

Troutt, Jason S., William E. Alborn, Marian Mosior, et al.. (2007). An apolipoprotein A-I mimetic dose-dependently increases the formation of preβ1 HDL in human plasma. Journal of Lipid Research. 49(3). 581–587. 36 indexed citations

12.

Schmidt, Robert J., James Ficorilli, Youyan Zhang, et al.. (2006). A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. Journal of Lipid Research. 47(5). 1037–1044. 14 indexed citations

13.

Zhou, Hongwen, Zhiqiang Li, David W. Jang, et al.. (2006). Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism. Journal of Lipid Research. 47(9). 2011–2019. 29 indexed citations

14.

Beyer, Thomas P., Robert J. Schmidt, Patricia Foxworthy, et al.. (2004). Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in Vivo. Journal of Pharmacology and Experimental Therapeutics. 309(3). 861–868. 34 indexed citations

15.

Yu, Liang, Suizhen Lin, Thomas P. Beyer, et al.. (2004). A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. Journal of Neurochemistry. 88(3). 623–634. 135 indexed citations

16.

Yu, Liang, Xian‐Cheng Jiang, Ruijie Liu, et al.. (2004). Liver X Receptors (LXRs) Regulate Apolipoprotein AIV-Implications of the Antiatherosclerotic Effect of LXR Agonists. Molecular Endocrinology. 18(8). 2000–2010. 26 indexed citations

17.

Jiang, Xian‐Cheng, Thomas P. Beyer, Zhiqiang Li, et al.. (2003). Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression. Journal of Biological Chemistry. 278(49). 49072–49078. 41 indexed citations

18.

Bramlett, Kelli, Keith A. Houck, Michele Dowless, et al.. (2003). A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor. Journal of Pharmacology and Experimental Therapeutics. 307(1). 291–296. 57 indexed citations

19.

Zhang, Youyan, Thomas P. Beyer, Kelli Bramlett, et al.. (2002). Liver X receptor and retinoic X receptor mediated ABCA1 regulation and cholesterol efflux in macrophage cells—messenger RNA measured by branched DNA technology. Molecular Genetics and Metabolism. 77(1-2). 150–158. 18 indexed citations

20.

Cao, Guoqing, Thomas P. Beyer, Xiao Yang, et al.. (2002). Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo. Journal of Biological Chemistry. 277(42). 39561–39565. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact